PHGE BiomX
- 0.4918
- -0.0172-3.38%
- 0.5776
- +0.0858+17.45%
BiomX News
BiomX Inc. Reports Q3 2024 Financial Turnaround
10-Q: Q3 2024 Earnings Report
BiomX GAAP EPS of -$0.31 Beats by $0.19
H.C. Wainwright Maintains BiomX(PHGE.US) With Buy Rating, Cuts Target Price to $2
BiomX Inc. (PHGE) Q3 2024 Earnings Call Transcript Summary
8-K: BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates
Express News | Biomx Inc: Qtrly Share Loss $0.31
Earnings Scheduled For November 14, 2024
Earnings Preview: BiomX to Report Financial Results Pre-market on November 14
$BiomX(PHGE.US)$ is scheduled to release its financial results pre-market on November 14 ET. Earnings PreviewAnalysts estimate $BiomX(PHGE.US)$ to post revenue of USD0 for 2024Q3, EPS is estimated
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024
NYSE American New 52-Week Highs And Lows
Express News | Biomx Inc - Warrants Will Expire on October 28
Express News | Biomx-Each Warrant Entitles Holder to Purchase One-Half of a Share of Common Stock at $115 per Share
Express News | Biomx Announces a Mandatory Unit Separation
BiomX Announces a Mandatory Unit Separation
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ...
BiomX Shares Phage Therapy Advances and Vision
Express News | Biomx Inc - to Initiate Phase 2B Trial in CF Patients With P. Aeruginosa Infections
Express News | Biomx Inc - FDA Grants Bx004 Fast Track and Orphan Drug Designation
BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Analysis
Price Target
No Data
No Data